Savient Pharmaceuticals (SVNT) Posts Q2 Loss of 35c/Share

August 14, 2013 7:06 AM EDT Send to a Friend

Savient Pharmaceuticals (NASDAQ: SVNT) reported Q2 EPS of ($0.35), $0.04 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Savient Pharmaceuticals (SVNT) Posts Q2 Loss of 35c/Share

Member Login

Free News Feed